Today: 10 April 2026
Subscribe
Browse Category

NYSE:HI 15 October 2025 - 10 January 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 10.01.2026

ROHM (TSE:6963) rose 3.5% to ¥2,385, pushing its 12-month return to 66.9% and trading at a 7.6% premium to the ¥2,204 fair value. Hillenbrand (HI) closed at $31.79, about 25% below its modeled intrinsic value of $42.57 per share. Arm Holdings’ fair value estimate slipped to $163.25 as analysts weighed AI gains against execution risks. Gibson Energy (TSX:GEI) trades at CA$25.01, below its CA$27.15 intrinsic value.
10 January 2026
···

Stock Market Today

  • FTSE 100 Stocks GSK and J Sainsbury Show Resilience Amid Global Uncertainty
    April 10, 2026, 3:55 AM EDT. Two FTSE 100 shares, GlaxoSmithKline (GSK) and J Sainsbury, stand out for their potential to outperform in 2026 despite geopolitical tensions. GSK, a global pharmaceutical firm, has risen 57% over the past year, underpinned by steady demand for essential medicines and a strong drug development pipeline. Its price-to-earnings ratio of 12.19 suggests value relative to the FTSE 100 average. J Sainsbury, a UK-based supermarket chain, benefits from consistent demand for food retail, showing a 48% gain over the last year. Its localized supply chain and competitive pricing enhance its defensive qualities. Both companies face challenges: regulatory risks for GSK and tight margins for Sainsbury, but their business models offer shelter amid market volatility.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 3:55 AM EDT FTSE 100 Stocks GSK and J Sainsbury Show Resilience Amid Global Uncertainty April 10, 2026, 3:55 AM EDT. Two FTSE 100 shares, GlaxoSmithKline (GSK) and J Sainsbury, stand out for their potential to outperform in 2026 despite geopolitical tensions. GSK, a global pharmaceutical firm, has risen 57% over the past year, underpinned by steady demand for essential medicines and a strong drug development pipeline. Its price-to-earnings ratio of 12.19 suggests value relative to the FTSE 100 average. J Sainsbury, a UK-based supermarket chain, benefits from
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Go toTop